Oral cholera vaccine development and use in Vietnam

Dang Duc Anh; Anna Lena Lopez; Hung Thi Mai Tran; Nguyen Van Cuong; Vu Dinh Thiem; Mohammad Ali; Jacqueline L Deen; Lorenz von Seidlein; David A Sack

doi:10.1371/journal.pmed.1001712

Oral cholera vaccine development and use in Vietnam

PLoS Med. 2014 Sep 2;11(9):e1001712. doi: 10.1371/journal.pmed.1001712. eCollection 2014 Sep.

Authors

Dang Duc Anh¹, Anna Lena Lopez², Hung Thi Mai Tran¹, Nguyen Van Cuong³, Vu Dinh Thiem¹, Mohammad Ali⁴, Jacqueline L Deen⁵, Lorenz von Seidlein⁵, David A Sack⁴

Affiliations

¹ National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
² University of the Philippines Manila-National Institutes of Health, Manila, Philippines.
³ National Expanded Programme on Immunization, Hanoi, Vietnam.
⁴ Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
⁵ Menzies School of Health Research, Casuarina, Northern Territory, Australia.

Abstract

Anna Lena Lopez and colleagues give an overview of the cholera situation in Vietnam and discuss how an oral cholera vaccine was developed and used as a component of a public health strategy against the disease.

Please see later in the article for the Editors' Summary

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Administration, Oral
Cholera / epidemiology*
Cholera / prevention & control*
Cholera Vaccines / administration & dosage*
Cholera Vaccines / therapeutic use
Drug Discovery / trends
Health Policy / trends
Humans
Vietnam / epidemiology

Substances

Cholera Vaccines

Grants and funding

The Bill and Melinda Gates Foundation (http://www.gatesfoundation.org) supported this work through the Delivering Oral Vaccine Effectively (DOVE) project, administered by the Johns Hopkins Bloomberg School of Public Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.